LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.031623
 29.19 27.76 1751 1863 0.9398 0.9797
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 30.90 27.76 1521 2032 0.7484 0.9086
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 30.90 27.76 1543 2032 0.7592 0.9130
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 30.90 27.76 314 2032 0.1545 0.4794
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 30.90 27.76 1897 2032 0.9334 0.9779
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 32.60 27.76 1695 2235 0.7581 0.9144
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 32.60 27.76 1720 2235 0.7693 0.9188
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 32.60 27.76 382 2235 0.1709 0.5130
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 32.60 27.76 2083 2235 0.9316 0.9778
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 34.30 27.76 1801 2449 0.7352 0.9070
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 34.30 27.76 1819 2449 0.7425 0.9100
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 34.30 27.76 463 2449 0.1890 0.5456
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 34.30 27.76 2194 2449 0.8956 0.9662
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 36.01 27.76 1955 2662 0.7342 0.9083
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 36.01 27.76 1977 2662 0.7424 0.9115
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 36.01 27.76 520 2662 0.1953 0.5606
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 36.01 27.76 2366 2662 0.8885 0.9644
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 37.71 27.76 2005 2877 0.6968 0.8949
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 37.71 27.76 2022 2877 0.7027 0.8973
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 37.71 27.76 583 2877 0.2026 0.5757
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 37.71 27.76 2506 2877 0.8709 0.9591
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 39.41 27.76 2200 3105 0.7084 0.9012
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 39.41 27.76 2220 3105 0.7148 0.9037
MN20160318_Q01
I06
MCF 10A-H2B-mCherry Neratinib
0.031623
 39.41 27.76 676 3105 0.2177 0.5986
MN20160318_Q01
M17
MCF 10A-H2B-mCherry Neratinib
0.031623
 39.41 27.76 2679 3105 0.8626 0.9570
MN20160318_Q01
M17